Medtronic plc (NYSE:MDT) initiated a recall Friday to address potential battery life issues with its insulin pumps.
As of July 31, the company has advised customers to pay close attention to their pumps’ battery alerts and alarms.
The action follows reports of shortened battery life, which Medtronic linked to pumps that had been dropped or impacted.
Also Read: Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion.
This damage to internal electrical components may result in the pump stopping insulin delivery earlier than expected, posing risks such as hyperglycemia (high blood sugar) or diabetic ketoacidosis (DKA).
DKA is ...
